CHMP positive for Elucirem (gadopiclenol) in the European Union (EU) for use in adults and children aged 2 years and over for MRI with contrast enhancement – Guerbet S.A + Bracco
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion concerning the granting of a marketing authorisation for… read more.